21 U.S.C. § 396 — Practice of medicine
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
Nothing in this chapter shall be construed to limit or interfere with the authority of a health care practitioner to prescribe or administer any legally marketed device to a patient for any condition or disease within a legitimate health care practitioner-patient relationship. This section shall not limit any existing authority of the Secretary to establish and enforce restrictions on the sale or distribution, or in the labeling, of a device that are part of a determination of substantial equivalence, established as a condition of approval, or promulgated through regulations. Further, this section shall not change any existing prohibition on the promotion of unapproved uses of legally marketed devices. (June 25, 1938, ch. 675, § 1006, formerly § 906, as added Pub. L. 105–115, title II, § 214 , Nov. 21, 1997 , 111 Stat. 2348 ; renumbered § 1006, Pub. L. 111–31, div. A, title I, § 101(b)(2) , June 22, 2009 , 123 Stat. 1784 .) Statutory Notes and Related Subsidiaries Effective Date Section effective 90 days after Nov. 21, 1997 , except as otherwise provided, see section 501 of Pub. L. 105–115 , set out as an Effective Date of 1997 Amendment note under section 321 of this title . CFR Title Parts 21 5 , 10
Related documents
- 42 U.S.C. § 7384t — Medical benefits#591053
- 21 U.S.C. § 393 — Food and Drug Administration#577187
- 22 U.S.C. § 4084 — Health care program#578669
- 42 U.S.C. § 17936 — Conditions on certain contacts as part of health care operations#588593
- 42 U.S.C. § 239c — Medical benefits#595460
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive